Current Approaches and Future Prospects of Nanomedicine in Tuberculosis Therapy

Author(s): Mohammad T. Athar*, Zabih Ullah

Journal Name: Recent Patents on Anti-Infective Drug Discovery
Continued as Recent Advances in Anti-Infective Drug Discovery

Volume 12 , Issue 2 , 2017

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: Tuberculosis (TB), which is caused by the Mycobacterium tuberculosis, is a serious threat and one of the major health problems worldwide.

Objective: In recent years, an estimated of 9.6 million TB cases occurred and 1.5 million death occurred due to TB worldwide.

Conclusion: The present review is an attempt to introduce this disease focusing on the pathophysiology of the disease, the current approaches and the related patents for treatment and the future planning for combating this disease.

Keywords: Tuberculosis therapy, first line treatment, fluorquinolones, second line therapy, diagnosis, new drug.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 03 May, 2018
Page: [120 - 127]
Pages: 8
DOI: 10.2174/1574891X12666170425122416
Price: $65

Article Metrics

PDF: 34